U.S. markets closed
  • S&P Futures

    4,076.25
    -13.75 (-0.34%)
     
  • Dow Futures

    34,069.00
    -87.00 (-0.25%)
     
  • Nasdaq Futures

    12,088.25
    -63.75 (-0.52%)
     
  • Russell 2000 Futures

    1,934.00
    -5.40 (-0.28%)
     
  • Crude Oil

    79.04
    +0.17 (+0.22%)
     
  • Gold

    1,940.80
    -4.50 (-0.23%)
     
  • Silver

    23.73
    -0.11 (-0.44%)
     
  • EUR/USD

    1.0859
    -0.0007 (-0.07%)
     
  • 10-Yr Bond

    3.5290
    -0.0220 (-0.62%)
     
  • Vix

    19.40
    -0.54 (-2.71%)
     
  • GBP/USD

    1.2304
    -0.0013 (-0.10%)
     
  • USD/JPY

    130.0410
    -0.0270 (-0.02%)
     
  • BTC-USD

    23,114.66
    +221.34 (+0.97%)
     
  • CMC Crypto 200

    524.33
    +5.54 (+1.07%)
     
  • FTSE 100

    7,771.70
    -13.17 (-0.17%)
     
  • Nikkei 225

    27,376.22
    +49.11 (+0.18%)
     

EU says Moderna COVID vaccine production can continue after contamination incident

BRUSSELS, Aug 27 (Reuters) - Production of Moderna COVID-19 vaccines at a plant of partner Rovi in Spain can continue after an initial assessment, the European Union drugs regulator said on Friday, as it continues its investigation of a contamination incident.

On Thursday Japan suspended the use of 1.63 million doses of the Moderna vaccine, with the company saying contamination could be due to a manufacturing issue on one of the production lines at its contract manufacturing site in Spain run by Rovi .

"COVID-19 vaccine production in Rovi is able to continue, following a preliminary risk assessment of the information received so far," the European Medicines Agency told Reuters in a statement on Friday.

"An investigation into the root cause is ongoing. EMA will be able to provide more information as the investigation progresses," it added. (Reporting by Francesco Guarascio @fraguarascio; Editing by Catherine Evans)